You have 9 free searches left this month | for more free features.

fruquintinib

Showing 26 - 42 of 42

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Colorectal Cancer Trial in Shanghai (Stereotactic Ablative Radiotherapy (SABR), Fruquintinib, Tislelizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Stereotactic Ablative Radiotherapy (SABR)
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 23, 2021

Drug Drug Interaction Trial in Cypress (Fruquintinib, Itraconazole, Rifampin)

Completed
  • Drug Drug Interaction
  • Fruquintinib
  • +2 more
  • Cypress, California
    WCCT
Jun 16, 2021

Metastatic NSCLC Trial in Shanghai (GB226, Fruquintinib)

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Mar 2, 2021

Metastatic Colorectal Cancer Trial in Harbin (Geptanolimab Injection, Fruquintinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Geptanolimab Injection
  • Fruquintinib
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
Feb 8, 2021

Colorectal Cancer Trial in China (fruquintinib, )

Completed
  • Colorectal Cancer
  • fruquintinib
  • placebo
  • Beijing, Beijing, China
  • +4 more
Jun 12, 2020

Food Effect of Fruquintinib in Health Subjects Trial in Shanghai (fruquintinib)

Completed
  • Food Effect of Fruquintinib in Health Subjects
  • fruquintinib
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Feb 13, 2020

Tumor Trial in Shanghai (Fruquintinib)

Completed
  • Tumor
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Feb 13, 2020

Healthy Trial in Nanjing (fruquintinib)

Completed
  • Healthy
  • fruquintinib
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Feb 12, 2020

Colorectal Cancer Trial in Guangzhou, Shanghai (fruquintinib)

Completed
  • Colorectal Cancer
  • fruquintinib
  • Guangzhou, Guangdong, China
  • +1 more
Feb 13, 2020

Metastatic Colorectal Cancer, Metastatic Colon Cancer Trial in Worldwide (Fruquintinib, Placebo)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Metastatic Colon Cancer
  • Fruquintinib
  • Placebo
  • Phoenix, Arizona
  • +152 more
Mar 10, 2022

Metastasis Colorectal Cancer Trial in Beijing (fruquintinib, Sintilimab)

Unknown status
  • Metastasis Colorectal Cancer
  • Beijing, China
    China PLAGH
Nov 25, 2019

Lung Cancer Trial in Guangzhou (Fruquintinib)

Withdrawn
  • Lung Cancer
  • Fruquintinib
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Nov 17, 2019

NSCLC Trial in Shanghai, Hangzhou (Fruquintinib, Gefitinib)

Completed
  • NSCLC
  • Shanghai, Shanghai, China
  • +1 more
Nov 14, 2019

NSCLC Trial in China (Fruquintinib, Placebo)

Completed
  • Non-small Cell Lung Cancer
  • Fruquintinib
  • Placebo
  • Beijing, Beijing, China
  • +11 more
Feb 12, 2020

Colorectal Cancer Trial in China (fruquintinib, )

Completed
  • Colorectal Cancer
  • fruquintinib
  • placebo
  • Hefei, Anhui, China
  • +14 more
Feb 13, 2020

Biliary Tract Adenocarcinoma Trial in China (Fruquintinib)

Unknown status
  • Biliary Tract Adenocarcinoma
  • Fruquintinib
  • Beijing, Beijing, China
  • +6 more
Nov 6, 2019

NSCLC Trial in China (Fruquintinib, Placebo)

Completed
  • NSCLC
  • Fruquintinib
  • Placebo
  • Beijing, Beijing, China
  • +10 more
Feb 11, 2019